CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Zhejiang Zhenyuan Share Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Zhejiang Zhenyuan Share Co Ltd
No. 558 Yanan East Road
Jishan Community, Yuecheng District
Phone: +86 57585746658p:+86 57585746658 SHAOXING, ZHJ  312000  China Ticker: 000705000705
Business Summary
Zhejiang Zhenyuan Share Co Ltd is a China-based company mainly engaged in the production and sales of pharmaceuticals. The Company's main businesses include pharmaceutical commerce, pharmaceutical industrialization and health services. The pharmaceutical industry business mainly includes the comprehensive production of raw materials and tablets, capsules, oral suspensions, oral solutions, small volume injections, freeze-dried powder injections and other preparations. The pharmaceutical commerce business mainly includes pharmaceutical wholesale and retail business. Its health services include maternal and childcare services, medical services and others. The Company conducts its businesses within domestic market and to overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries
5912 Drug stores and proprietary stores
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board HaimingWu 57 10/29/2021 10/29/2021
Vice Chairman of the Board, General Manager JunChai 44 4/29/2024 9/16/2017
Chief Financial Officer, Secretary of the Board YufengZhang 40 4/29/2024 10/13/2023
9 additional Officers and Directors records available in full report.

General Information
Number of Employees: 2,016 (As of 12/31/2023)
Outstanding Shares: 334,123,286 (As of 9/30/2024)
Shareholders: 43,952
Stock Exchange: SHE
Fax Number: +86 57585148805


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, January 29, 2025